Controlling the role of BPC 157 likely involves its particular interaction with the major systems involved in wound healing, such as the NO-system (counteracted harmful events, arising from either NO-blockade or NOS-substrate application) (Sikiric et al., 2014) and the prostaglandins system (i.e., large extent of the counteracted NSAIDs toxicity (Sikiric et al., 2013) as well as counteracted developing and already formed adjuvant arthritis in rats (Sikiric et al., 1997c))
Future studies are still needed evaluating the safety and efficacy of BPC 157 in humans
One of the most promising therapies in regenerative medicine today is BPC 157 peptide therapy
At Prisk Orthopaedics and Wellness (POW), we remain committed to safe, evidence-based regenerative treatments
References: Seiwerth, S., Milavic, M., Vukojevic, J., Gojkovic, S., Krezic, I., Vuletic, L